Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04975958
Title Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adlai Nortye Biopharma Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Florida Cancer Specialists - Lake Mary Cancer Center Lake Mary Florida 32746 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
NYU Grossman School of Medicine New York New York 10016 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field